The OMF Patient Forum is an interactive social network much like Facebook except private and confidential. Many patients refer to it as Eyebook. The Forum allows patients, their friends and loved ones, and even doctors to interact with each other, share valuable treatment information, and learn more about ocular melanoma in a secure environment.

Currently, there are over 1,700 members on the Patient Forum. To join, just visit the forum, sign up, and begin creating your own custom profile. You can upload as little or as much information as you like and begin interacting and learning today.

SIGN UP NOW

> Private Ocular Melanoma Friends & Family Group 
> Eye Cancer Group

> Also, be sure and 'Like' OMF on Facebook

> OCU-MEL Listserv
> Choroidal Melanoma Yahoo Group
> Eye Cancer Network Patient Bulletin Board

> Eye Cancer Network (run by Dr. Paul Finger)
> National Cancer Institute (NCI) PDQ on Intraocular Melanoma
> Treatment Trials
> EyeMelanoma.org - educational and support resources for patients and their families

> The Eyes Have It - by Dove Karn, ocular melanoma patient
> FightCancerWithMe - by Tom Loverro, choroidal melanoma patient
> LostEye - by Jay Adkisson, choroidal melanoma patient who lost his eye in 2000

A Cure In Sight (ACIS), a not-for-profit organization founded by OM survivor and activist Melody Kling, is dedicated to raising ocular melanoma awareness and to helping those with OM find and pay for the treatments that they need. ACIS generates funds through the sale of OM awareness products, by accepting donations of money, travel vouchers/frequent flyer miles, timeshare weeks, hotel vouchers, gift cards and gas cards to help patients find and pay for necessary treatments otherwise outside of their medical budget.

> Understanding the Important Role of Adherence in the Medical Management of Cancer
> Fear of Recurrence and Late Effects: Living with Uncertainty
> Cancer and the Workplace
> View all general workshop podcasts from CancerCare..

Nothing on this site is meant to replace the opinion of a medical professional. Please consult with an ophthalmologist and oncologist, at a minimum.

Full Legal Disclaimer